Intel is absorbing two simultaneous pressures this week: the continued gravitational pull of its $15 billion equity offering announced Sunday, and a stock that has now shed 11% over the past month from its June peak above $139 to close at $97.71.
The clearest new signal this week is in options. Put demand has jumped to its most elevated level in months, with the put/call ratio hitting 1.03 — running 2.6 standard deviations above its 20-day average of 0.97. That z-score is close to the highest defensive reading of the past year, outright above the 52-week low of 0.61 and closing in on the annual peak of 1.16. Options traders are pricing in more downside risk than at almost any point in the last twelve months. That shift is notable precisely because it has arrived after the dilutive offering, not before — hedgers appear to be reacting to where the stock has landed, not front-running an unknown catalyst.
Short interest tells a quieter story, and that contrast matters. Bears have actually been trimming, not adding. Short interest has fallen 16.6% over the past month to just 2.56% of free float — the lowest level in at least three months — and slipped another 0.65% on the week. Borrow availability remains entirely unconstrained. The lending pool is effectively bottomless relative to current short demand, meaning there is no squeeze pressure and no friction for anyone who wants to build a new short position. The borrow cost of 0.34% confirms the same: this is among the cheapest stocks in the semiconductor space to borrow. Short sellers are not piling in after the offering — if anything, they stepped aside into the dilution event.
The Street remains fractured in a way that reflects genuine uncertainty. The consensus is officially "buy," with 12 analysts on that side, but the price target spread tells the real story. Vivek Arya at BofA Securities holds a $160 target — almost 64% above the current price. Against that, JPMorgan's Harlan Sur is at $85 with an Underweight rating, and Morgan Stanley's Joseph Moore is at $84 with an Equal-Weight. Both raised targets after July 24 earnings but remain well below where Intel trades today. This morning, UBS's Timothy Arcuri cut his target to $112 from $121, maintaining Neutral — a fresh move that acknowledges the offering's dilutive math. The mean target of $114.88 implies about 17% upside, but that consensus is doing heavy averaging work across a $75 gap between the most bearish and most bullish targets. The bull case centres on foundry ambitions and AI-related demand. The bear case points directly at Intel Foundry's mounting losses, high capex for Intel 14A, and the EPS compression that comes with Panther Lake and Granite Rapids ramp costs. The PE multiple at 52.7x and EV/EBITDA at 19.8x — both compressing over the past month — reflect a market trying to reprice that risk.
One factor score stands out as a countervailing signal. EPS momentum is running in the 91st percentile on a 30-day basis and 90th on 90 days — the forward earnings revision trend has been sharply positive. The analyst recommendation divergence score ranks in the 87th percentile, meaning the spread of views is wider than almost all peers, which is consistent with the target dispersion described above. Days-to-cover ranks in the 88th percentile, reflecting how lightly shorted the name is relative to its average daily volume — another signal that the short community has not turned aggressive despite the offering overhang.
Among peers, the week has been mixed. AMD fell 8.5% while MKSI dropped 8.2%, making Intel's 3.1% weekly decline look contained by comparison. ENTG bucked the trend with a 3.9% gain, continuing its outperformance streak. Intel's next earnings event is pencilled in for October 22. The last print on July 24 produced an 8.5% single-day drop and a 10% five-day decline — a pattern now embedded in how options traders are calibrating downside risk heading into the next quarter.
The critical question through September is whether the $15 billion offering pricing gets absorbed cleanly, or whether it continues to act as a ceiling on recoveries — with the options market's current defensive tilt suggesting the answer, for now, is the latter.
See the live data behind this article on ORTEX.
Open INTC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
